Related references
Note: Only part of the references are listed.Clinical Trials of Intravenous Immunoglobulin for Alzheimer's Disease
Norman Relkin
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2
Milene Vandal et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Brain Uptake of a Fluorescent Vector Targeting the Transferrin Receptor: A Novel Application of in Situ Brain Perfusion
Wael Alata et al.
MOLECULAR PHARMACEUTICS (2014)
Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease
Tuan Minh Do et al.
NEUROPHARMACOLOGY (2014)
Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier
Isabelle St-Amour et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer's Disease with Combined Amyloid-beta and Cerebrovascular Pathology
Panayiota Papadopoulos et al.
PLOS ONE (2013)
Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer's Disease
Dharmini C. Mehta et al.
PHARMACEUTICAL RESEARCH (2013)
Methodologies to Assess Drug Permeation Through the Blood-Brain Barrier for Pharmaceutical Research
Celine Passeleu-Le Bourdonnec et al.
PHARMACEUTICAL RESEARCH (2013)
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies
Zhichun Chen et al.
PROGRESS IN NEUROBIOLOGY (2013)
Cerebrovascular Effects of Apolipoprotein E Implications for Alzheimer Disease
Berislav V. Zlokovic
JAMA NEUROLOGY (2013)
Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade
Kie Honjo et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging
William J. Jagust et al.
JOURNAL OF NEUROSCIENCE (2012)
Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer's Disease
Jesse M. Hunter et al.
PLOS ONE (2012)
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
David M. Holtzman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The Case for Blood-Brain Barrier Dysfunction in the Pathogenesis of Alzheimer's Disease
Brian Jeynes et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Brain fuel metabolism, aging, and Alzheimer's disease
Stephen Cunnane et al.
NUTRITION (2011)
Worldwide Allele Frequencies of the Human Apolipoprotein E Gene: Climate, Local Adaptations, and Evolutionary History
Dan T. A. Eisenberg et al.
AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY (2010)
Impaired Orthotopic Glioma Growth and Vascularization in Transgenic Mouse Models of Alzheimer's Disease
Daniel Paris et al.
JOURNAL OF NEUROSCIENCE (2010)
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
Robert W. Mahley et al.
JOURNAL OF LIPID RESEARCH (2009)
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
Norman R. Relkin et al.
NEUROBIOLOGY OF AGING (2009)
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study
Melissa Ouellet et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
The Role of Apolipoprotein E in Alzheimer's Disease
Jungsu Kim et al.
NEURON (2009)
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
Fanchon Bourasset et al.
NEUROPHARMACOLOGY (2009)
Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease
Miles C. Miller et al.
BRAIN RESEARCH (2008)
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease
Justin Paul et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease
GD Lee et al.
BRAIN RESEARCH BULLETIN (2005)
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease - FDG-PET studies in MCI and AD
L Mosconi
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Neurovascular regulation in the normal brain and in Alzheimer's disease
C Iadecola
NATURE REVIEWS NEUROSCIENCE (2004)
Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis
D Paris et al.
NEUROSCIENCE LETTERS (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease
S Salloway et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice
C Dagenais et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Share Paper
